相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Establishing a new rat model of central venous sinus thrombosis and analyzing its pathophysiological and apoptotic changes
Hui Yang et al.
JOURNAL OF NEUROSCIENCE METHODS (2012)
The selective adhesion molecule inhibitor Natalizumab decreases multiple myeloma cell growth in the bone marrow microenvironment: therapeutic implications
Klaus Podar et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Targeting the interplay between myeloma cells and the bone marrow microenvironment in myeloma
Masahiro Abe
INTERNATIONAL JOURNAL OF HEMATOLOGY (2011)
Future Directions of Next-Generation Novel Therapies, Combination Approaches, and the Development of Personalized Medicine in Myeloma
Constantine S. Mitsiades et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Overcoming in vivo barriers to targeted nanodelivery
Adrian Chrastina et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2011)
Multifunctionality of lipid-core micelles for drug delivery and tumour targeting
Rupa R. Sawant et al.
MOLECULAR MEMBRANE BIOLOGY (2010)
Advances in polymeric micelles for drug delivery and tumor targeting
Uttam Kedar et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2010)
Mixed pH-Sensitive Polymeric Micelles for Combination Drug Delivery
Younsoo Bae et al.
PHARMACEUTICAL RESEARCH (2010)
Fullerenol-Cytotoxic Conjugates for Cancer Chemotherapy
Padmaparna Chaudhuri et al.
ACS NANO (2009)
Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect
H. Maeda et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2009)
Multifunctional Micellar Nanomedicine for Cancer Therapy
Elvin Blanco et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2009)
Selectively Targeting T- and B-Cell Lymphomas: A Benzothiazole Antagonist of α4β1 Integrin
Richard D. Carpenter et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Bortezomib overcomes cell adhesion-mediated drug resistance through downregulation of VLA-4 expression in multiple myeloma
K. Noborio-Hatano et al.
ONCOGENE (2009)
Drug delivery with carbon nanotubes for in vivo cancer treatment
Zhuang Liu et al.
CANCER RESEARCH (2008)
ANTI-ADHESION evolves to a promising therapeutic concept in oncology
R. Schmidmaier et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Mouse models of human myeloma
Constantine S. Mitsiades et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2007)
JS-K, a GST-activated nitric oxide generator, induces DNA double-strand breaks, activates DNA damage response pathways, and induces apoptosis in vitro and in vivo in human multiple myeloma cells
Tanyel Kiziltepe et al.
BLOOD (2007)
Pegylated liposomal doxorubicin and immunomodulatory drug combinations in multiple myeloma: Rationale and clinical experience
Asher Alban Chanan-Khan et al.
CLINICAL LYMPHOMA & MYELOMA (2007)
Micellar nanocarriers: Pharmaceutical perspectives
V. P. Torchilin
PHARMACEUTICAL RESEARCH (2007)
Prognostic value of bone marrow angiogenesis in multiple myeloma: Use of light microscopy as well as computerized image analyzer in the assessment of microvessel density and total vascular area in multiple myeloma and its correlation with various clinical, histological, and laboratory parameters
Sahibinder Singh Bhatti et al.
AMERICAN JOURNAL OF HEMATOLOGY (2006)
Determination of doxorubicin levels in whole tumor and tumor nuclei in murine breast cancer tumors
KM Laginha et al.
CLINICAL CANCER RESEARCH (2005)
Amelioration of doxorubicin-induced cardiac and renal toxicity by pirfenidone in rats
SN Giri et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2004)
In vitro characterization of PEGylated phospholipid micelles for improved drug solubilization:: Effects of PEG chain length and PC incorporation
B Ashok et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
Bone marrow angiogenic ability and expression of angiogenic cytokines in myeloma: evidence favoring loss of marrow angiogenesis inhibitory activity with disease progression
S Kumar et al.
BLOOD (2004)
Role of liposomal anthracyclines in the treatment of multiple myeloma
MA Hussein et al.
SEMINARS IN ONCOLOGY (2004)
Rational design of potent and selective VLA-4 inhibitors and their utility in the treatment of asthma
J Singh et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2004)
Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia
T Matsunaga et al.
NATURE MEDICINE (2003)
Novel therapeutic approaches for multiple myeloma
T Hideshima et al.
IMMUNOLOGICAL REVIEWS (2003)
Polyethylene glycol-diacyllipid micelles demonstrate increased acculumation in subcutaneous tumors in mice
AN Lukyanov et al.
PHARMACEUTICAL RESEARCH (2002)
Therapeutic cancer targeting peptides
OH Aina et al.
BIOPOLYMERS (2002)
ATM phosphorylates histone H2AX in response to DNA double-strand breaks
S Burma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Spherical micelles and other self-assembled structures in dilute aqueous mixtures of poly(ethylene glycol) lipids
M Johnsson et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2001)
VLA-4-dependent myeloma cell adhesion
F Sanz-Rodríguez et al.
LEUKEMIA & LYMPHOMA (2001)
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
H Maeda et al.
JOURNAL OF CONTROLLED RELEASE (2000)
分享论文
